Courtney Coppola, APRN
Adult Health · Peabody, MANPI 1134787294
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 98 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 22 manufacturers, the largest accounting for just 18.7% — the pattern of someone who eats at a lot of different presentations. Among adult health clinicians in MA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 98 payments — averaging $27.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Cequr Corporation$500
- Xeris Pharmaceuticals, Inc.$260
- AstraZeneca$237
- Idorsia Pharmaceuticals US Inc$198
- Pfizer$194
- AbbVie$176
- plus $1K from 16 others
What the payments were for
- Food & beverage$2,669100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Cequr Corporation | 1 | $500 |
| Xeris Pharmaceuticals, Inc. | 12 | $260 |
| AstraZeneca | 12 | $237 |
| Idorsia Pharmaceuticals US Inc | 4 | $198 |
| Pfizer | 10 | $194 |
| AbbVie | 8 | $176 |
| Novo Nordisk | 8 | $158 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 6 | $145 |
| Amgen | 7 | $145 |
| Boehringer Ingelheim | 6 | $116 |
| Otsuka America Pharmaceutical, Inc. | 5 | $105 |
| Lilly USA, LLC | 4 | $83 |
| Exact Sciences | 3 | $78 |
| Averitas Pharma Inc. | 2 | $57 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $54 |
| GSK | 1 | $30 |
| Novartis | 2 | $30 |
| Corcept Therapeutics | 1 | $25 |
| Mannkind Corporation | 1 | $24 |
| Antares Pharma, Inc. | 1 | $24 |
| Medtronic | 1 | $18 |
| E.r. Squibb & Sons, L.L.C. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- CeQur Simplicity$500
- QUVIVIQ$125
How this compares
$2,669 in reported general payments places this provider in the 90th percentile of 671 adult health providers in Massachusetts.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Albuterol Sulfate HfaAlbuterol Sulfate | 14 | $341 |
| Lisinopril | 22 | $184 |
| Simvastatin | 19 | $163 |
| Gabapentin | 15 | $159 |
| Losartan Potassium | 16 | $96 |
| Lorazepam | 15 | $43 |
| Escitalopram Oxalate | 11 | $17 |
Paid to pharmacies, not to this prescriber.
Other adult health in Peabody
- Krista TuckerBoston$157K
- Kathleen Dietz LovettHyannis$123K
- Caitlin ReenCharlestown$89K
- Tiffini ReedyFall River$58K
- Christine AgiusBoston$32K
- Amy PierreJamaica Plain$27K
- Josie BazemoreBoston$22K
- Jill TerrienWorcester$18K
- Beverly HarrisGroton$15K
- Kelly GoodwinFranklin$14K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.